Showing results (121-130 of 790) with videos related to

Sort By:
Pageof 79
Nature Communications|April 15, 2020
Sex-associated molecular differences for cancer immunotherapyYouqiong Ye, Ying Jing, Liang Li, et al.
Molecular Cancer Therapeutics|October 17, 2006
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cellsRaoul Tibes, Yihua Qiu, Yiling Lu, et al.
British Journal of Haematology|January 18, 2006
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphomaGeorgios V Georgakis, Yang Li, Georgios Z Rassidakis, et al.
International Journal of Clinical and Experimental Medicine|January 9, 2010
Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancerChan H Han, Qingyi Wei, Karen K Lu, et al.
Molecular Pharmacology|June 20, 2006
Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to Paclitaxel, Doxorubicin, and gemcitabineKe Liang, Yang Lu, Xinqun Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2006
A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partnersZhiyong Ding, Jiyong Liang, Yiling Lu, et al.
EMBO Reports|April 19, 2012
AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosisHaitao Ji, Zhiyong Ding, David Hawke, et al.
Nature Genetics|February 11, 2026
Pan-cancer inference and validation of hypermorphic, hypomorphic and neomorphic mutationsSomnath Tagore, Samuel Tsang, Carla Tangermann, et al.
NPJ Precision Oncology|June 13, 2025
Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancerDaniel Bottomly, Christina Zheng, Allison L Creason, et al.
Expert Review of Proteomics|September 13, 2019
Proteomics advances for precision therapy in ovarian cancerMarilyne Labrie, Nicholas D Kendsersky, Hongli Ma, et al.
Pageof 79